As
one of the empirical models of the chronic central inflammatory
response, a spinal cord injury (SCI) deteriorates the neuronal survival
and results in irreversible motor and sensory dysfunction below the
injury area. Our previous studies have reported that maize bran feruloylated
oligosaccharides (FOs) exert significant anti-inflammatory activities
both in diabetes and colitis. However, no direct evidence of FOs alleviating
central nervous inflammation was stated. This study aimed to investigate
the therapeutic effect of FOs on SCI and its potential mechanism.
Our results indicated that 4 weeks of FO administration effectively
mitigated the inflammatory response via decreasing
the number of microglia (labelled with Iba1), result in the expression
of IL-1α, IL-2, IL-6, IL-18 and TNF-α downregulating,
but the level of IL-10 and BDNF increases in the injured spinal cord.
Moreover, FOs enhanced neuronal survival, ameliorated the scar cavities,
and improved behaviors, including Basso mouse scale (BMS) scores and
the gait of mice after SCI. Together, these results demonstrated that
administration of FOs showed superior functional recovery effects
in a SCI model. Also, FOs may modulate inflammatory activities by
regulating the expression of proinflammatory factors, decreasing the
production of inflammatory cells, and promoting functional recovery
through the MAPK pathway following SCI.